ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

Mammography Reports Complete; Breast Project to Continue

March 25, 1977

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009